Physicians' preference for controller medication in mild persistent asthma


Creative Commons License

BAKIRTAŞ A., Kutlu A., BAÇÇIOĞLU A., Erkekol F. O., BAVBEK S., Kalayci O.

RESPIRATORY MEDICINE, cilt.131, ss.236-240, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 131
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.rmed.2017.08.029
  • Dergi Adı: RESPIRATORY MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.236-240
  • Anahtar Kelimeler: Asthma, Mild, Persistent, Physician, Preference, Treatment, SEASONAL ALLERGIC RHINITIS, INHALED CORTICOSTEROIDS, MONTELUKAST, CHILDREN, INSIGHTS, REALITY
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Although the asthma guidelines recommend inhaled corticosteroids(ICS) or leukotriene receptor antagonists-(LTRAs) for the treatment of mild persistent asthma, factors governing the physicians' preference are unknown. We aimed to investigate the preference of physicians for the controller medication and the factors governing their choice.